NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Independent Clinical Trial Required) (PAR-24-229)

Sponsor: National Institute of Neurological Disorders and Stroke

Due Date: Multiple due dates; see announcement.

NINDS Alzheimers Disease-Related Dementias (ADRD) Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed) (PAR-24-212)

Sponsor: National Institute of Neurological Disorders and Stroke, National Institute on Aging

Due Date: Multiple due dates; see announcement.

NINDS Alzheimers Disease-Related Dementias (ADRD) Advanced Postdoctoral Career Transition Award (K99/R00 Independent Clinical Trial Not Allowed) (PAR-24-213)

Sponsor: National Institute of Neurological Disorders and Stroke, National Institute on Aging

Due Date: Multiple due dates; see announcement.

Alzheimer's Drug-Development Program (U01 Clinical Trial Optional) (PAR-24-223)

Sponsor: National Institute on Aging

Award: Application budgets are limited to $1,500,000 in direct costs per year. For Early Stage projects, the project period is limited to five years. For Late Stage projects, the project period is limited to four years.

Due Date: Multiple due dates; see announcement.

Summer Research Education Experience Program (R25 Clinical Trial Not Allowed) (PAR-24-204)

Sponsor: National Institutes of Health

Award: A project period of up to five years may be requested. Funds may be requested for a minimum of 8 weeks and a maximum of 15 weeks of research education experience each year. Proposed, budgets cannot exceed $125,000 direct costs per year.

Due Date: Multiple due dates; see announcement.

BRAIN Initiative: Brain-Behavior Quantification and Synchronization Transformative and Integrative Models of Behavior at the Organismal Level (U01 Clinical Trial Optional) (RFA-DA-24-040)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

BRAIN Initiative: Brain-Behavior Quantification and Synchronization Transformative and Integrative Models of Behavior at the Organismal Level (U01 Clinical Trials Not Allowed) (RFA-DA-24-041)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

Intervention Research to Improve Native American Health (R34 Clinical Trial Optional) (PAR-23-285)

Sponsor: National Institutes of Health

Award: Applicants may request direct costs of up to $450,000 for three years. Although variations from year to year are permissible, in no case may any year be more than $225,000 in direct costs, and total direct costs for the entire project period may not exceed $450,000.

Due Date: Multiple due dates; see announcement.

NINDS Research Education Opportunities (R25 Clinical Trial Not Allowed) (PAR-24-200)

Sponsor: National Institute of Neurological Disorders and Stroke

Award: Application budgets are are limited to a maximum of $250,000 direct cost per year. The maximum project period is 5 years.

Due Date: Multiple due dates; see announcement.

Notice of Special Interest (NOSI): Promoting Data Reuse for Health Research (NOT-OD-24-096)

Sponsor: National Institutes of Health

Due Date: This Notice of Special Interest (NOSI) solicits competitive revision applications. Multiple due dates; see announcement.

Notice of Special Interest (NOSI): Administrative Supplements to Promote Diversity for NINDS ADRD Awardees (NOT-NS-24-071)

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Due Date: Notice expires February 15, 2027.

BRAIN Initiative: Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 Clinical Trial Optional) (RFA-NS-24-016)

Sponsor: National Institutes of Health

Award: Applicants must not exceed $500,000 in direct costs per year for the UG3 phase and should rarely exceed $1,500,000 direct costs per year for the UH3 phase.

Due Date: Multiple due dates; see announcement.

BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UH3 Clinical Trial Optional) (RFA-NS-24-017)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

BRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation Technologies in the Human CNS (R18 - Clinical Trial Not Allowed) (RFA-NS-24-031)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed) (PAR-24-144)

Sponsor: National Institutes of Health

Award: Applications may request up to $100,000 direct costs/year, excluding consortium facilities and administrative (F&A) costs. The scope of the proposed project should determine the project period. The maximum period of support is 4 years.

Due Date: Multiple due dates; see announcement.